Ehime University · University Hospital

Research keywordsCOVID-19関連肺アスペルギルス症・レセプトデータ・高度治療施設・後方視的コホート

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Coronavirus disease 2019 (COVID‐19)‐associated pulmonary aspergillosis (CAPA) is one of the noticeable complications of COVID‐19 and its incidence varies widely. In Japan, research on the incidence, risk factors and mortality associated with CAPA is limited.2019 · 論文
• Incidence and risk factors for coronavirus disease 2019‐associated pulmonary aspergillosis using administrative claims data2019 · 論文
• A retrospective cohort study, using administrative claims data obtained from advanced treatment centers in Japan, was conducted between December 1, 2015, and January 31, 2023. Participants included individuals aged 18 years or older with aNSCLC who received immunotherapy, using immune checkpoint inhibitor (ICI) treatment or conventional chemotherapy.2015 · 論文
• Takaaki Yano, Yasutaka Ihara, Hisako Yoshida, Takumi Imai, Ryota Kawai, Ayumi Shintani論文

• Official profile